Exp Clin Endocrinol DiabetesDOI: 10.1055/a-0934-5666 Background & Aim Dyslipidaemia is highly prevalent among postmenopausal women and its management represents a keystone in the prevention of the worldwide increase in cardiovascular morbidity and mortality. Therapy choices for menopause-associated dyslipidaemia are limited and a matter of debate. So, it becomes prudent to search for natural safe alternatives. Vitamin D (VD) has been acknowledged as an essential factor in cardiovascular health....
Exp Clin Endocrinol DiabetesDOI: 10.1055/a-0919-4388 Purpose The authors review the clinical outcomes of patients with primary hypophysitis (PH). Methods Patients with PH who were followed up between 2007 and 2018 at our clinic were evaluated. Clinical, endocrinologic, pathologic, radiologic findings and treatment modalities were assessed. Results Seventeen patients with PH were assessed. The median follow-up was 24 (range, 6–84) months. Histologic confirmation was available in 8 patients (6 lymphocytic...
Exp Clin Endocrinol DiabetesDOI: 10.1055/a-0921-6420 Background Metformin reduced prolactin levels only in women with hyperprolactinemia. Objective The purpose of this case-control study was to compare metformin action on lactoctrope function between women receiving oral contraceptive pills and women not using hormonal contraception. Methods The study included two groups of matched women with elevated prolactin levels and new-onset prediabetes or diabetes. The first group consisted of 20 women...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου